MedTrace Logo

Candida Host Defense Response After Septic Shock in the Critically Ill

NCT03136081 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2017-05-02

No results posted yet for this study

Summary

Septic shock is associated with acquired immunoparalysis which is associated with a high risk of nosocomial acquired infection. Nosocomial candidiasis is associated with a 50% rate of mortality but is difficult to diagnose. The use of colonization indexes and risk factors on the other hand expose to unnecessary use of antifungals. The aim of the present study is to evaluate whether the host response to infection associated with candida biomarkers would help to anticipate the candidiasis onset.

Conditions

  • Septic Shock
  • Candidiasis

Interventions

DIAGNOSTIC_TEST

Candidiasis infection occurence

Candidiasis infection occurence

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03136081 on ClinicalTrials.gov